Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jamanetworkopen.2021.47794 | DOI Listing |
Front Public Health
January 2025
Triveni Rai Kisan Mahila Mahavidyalaya, D. D. U. Gorakhpur University, Kushinagar, India.
Background And Objective: This study delves into the parenting cognition perspectives on COVID-19 in children, exploring symptoms, transmission modes, and protective measures. It aims to correlate these perspectives with sociodemographic factors and employ advanced machine-learning techniques for comprehensive analysis.
Method: Data collection involved a semi-structured questionnaire covering parental knowledge and attitude on COVID-19 symptoms, transmission, protective measures, and government satisfaction.
Curr Opin Oncol
December 2024
Dermatology department, Hôpital Erasme-HUB.
Purpose Of Review: Squamous cell carcinoma (SCC) is the second most common skin cancer, with an increasing incidence. This review highlights this past year's advances regarding the understanding of its pathogenesis, newly introduced diagnostic methods and updates in prevention and treatment.
Recent Findings: While the pathogenesis of SCC progression remains unclear, new sequencing techniques are helping to better characterize these tumours at the molecular level.
Animals (Basel)
January 2025
Equestrian Performance Research Centre, Hartpury University, Gloucester GL19 3BE, UK.
This paper highlights and summarizes the experiences and perceptions of European equestrian educational experts from a workshop held at the French National Riding School in Saumur. The workshop, which brought together fifty leading experts, aimed to address challenges in equestrian education, identify common ground, and share best practices. Using 'The World Café' method, the participants were divided into groups to discuss four key topics: the relationship between horses and humans, diversity of perspectives versus common ground, training philosophy, and social acceptability.
View Article and Find Full Text PDFGeorgian Med News
November 2024
Aim: This study aims to assess the cost-effectiveness of treatment with biological drugs-specifically infliximab, adalimumab, and rituximab-both as monotherapy and in combination therapy for patients with rheumatoid arthritis. Additionally, we will identify the factors that influence this process.
Materials And Methods: A total of 60 patients with moderate to severe rheumatoid arthritis (DAS28 > 3.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!